Janux Therapeutics kompaniyasidagi eng so‘nggi ish o‘rinlari

Janux Therapeutics is a biotechnology company developing tumor-activated immunotherapies for cancer treatment. Its research centers on precision-engineered bispecific molecules intended to activate immune responses within the tumor microenvironment, helping direct T cells toward cancer cells while limiting activity elsewhere. The company is advancing clinical development of its lead program, JANX007, for prostate cancer.